[EN] CATHEPSIN CYSTEINE PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DES PROTEASES A CYSTEINE DU TYPE CATHEPSINE
申请人:MERCK FROSST CANADA INC
公开号:WO2005056529A1
公开(公告)日:2005-06-23
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
这项发明涉及一类新型化合物,它们是半胱氨酸蛋白酶抑制剂,包括但不限于对卡特普辛K、L、S和B的抑制剂。这些化合物对于治疗需要抑制骨吸收的疾病,如骨质疏松症,非常有用。